𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effective administration of heparin and antibiotic prophylaxis

✍ Scribed by Mr C. M. E. Avery; N. Jamieson; R. Y. Calne

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
217 KB
Volume
82
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Administration of heparin and antibiotic
Administration of heparin and antibiotic prophylaxis
✍ Mr C. M. Avery; N. V. Jamieson; R. Y. Calne πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

An audit was performed to examine the time of administra-undergoing elective procedures and in only 22-7 per cent of tion of heparin and antiiiotic prophylaxis to patients at risk emergencies. Antiiiotic prophylaxis was given before of deep vein thrombosis, pulmonary embolism and postoperation or at

A randomized study of a semisynthetic he
A randomized study of a semisynthetic heparin analogue and heparin in prophylaxis of deep vein thrombosis
✍ Dr. S. TΓΆrngren; K. Kettunen; J. Lahtinen; K. Koppenhagen; P. BrΓΌcke; P. Hartl; πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 377 KB πŸ‘ 2 views

## Abstract The prophylactic effect of a semisynthetic heparin analogue (SSHA) on deep vein thrombosis was investigated in a prospective double-blind multicentre trial. 440 major general surgical and gynaecological patients were randomized to one of three treatment groups: 50 mg SSHA, 37Β·5 mg SSHA

Heparin/dihydroergotamine for venous thr
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery
✍ Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. MΓΈller-Larsen; V. E. Knud πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 495 KB πŸ‘ 2 views

Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo